RxDoctor Payments Data

Anne Green

Psychiatric/Mental Health · Knoxville, TNNPI 1588057806

Payments from drug & device makers

$3,418in general payments, 2019–2025

Across 203 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$690
  • Teva Pharmaceuticals USA, Inc.$553
  • Johnson & Johnson$376
  • Alkermes, Inc.$311
  • Lundbeck LLC$275
  • E.r. Squibb & Sons, L.L.C.$262
  • plus $951 from 8 others

What the payments were for

  • Food & beverage$3,25195%
  • Education$1665%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,418 in reported general payments places this provider in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$10,956
Medicare patients
46
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate143$490,272
Austedo XrDeutetrabenazine21$164,581
Abilify MaintenaAripiprazole58$157,771
Invega TrinzaPaliperidone Palmitate12$130,921
Risperdal ConstaRisperidone Microspheres38$87,027
VivitrolNaltrexone Microspheres18$31,757
ClozarilClozapine11$23,377
VraylarCariprazine Hcl16$23,110
Haloperidol Decanoate178$11,152
Clozapine98$10,559
Lurasidone Hcl29$8,891
Paliperidone ErPaliperidone52$6,640
TrintellixVortioxetine Hydrobromide11$6,287
Hydroxyzine Hcl188$4,026
Risperidone OdtRisperidone13$3,963

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$376$708,220193 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$553$164,58121 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$254$157,77158 claims
Alkermes, Inc.Vivitrol$311$31,75718 claims
AbbVieVraylar$131$23,11016 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$15$6,28711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →